Psyence Biomedical (PBM) Depreciation & Amortization - Total (2024 - 2025)
Psyence Biomedical's (PBM) quarterly Depreciation & Amortization - Total came in at -$1330.0 in Q3 2025, down 230.91% year-on-year from $1016.0 in Q3 2024, and down 230.91% quarter-over-quarter from $1016.0 in Q3 2024.
Psyence Biomedical (PBM) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends
Psyence Biomedical's Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at -$1330.0 for Q3 2025.
- On a quarterly basis, Depreciation & Amortization - Total fell 230.91% year-over-year to -$1330.0 in Q3 2025; TTM through Mar 2026 was -$314.0, a 130.91% decrease from a year earlier, with the FY2025 full-year figure at -$4268.0, down 1878.33% from the prior year.
- Depreciation & Amortization - Total slipped to -$1330.0 in Q3 2025 per PBM's latest filing, from $1016.0 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $1016.0 in Q3 2024 and bottomed at -$1330.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,330.00 |
| Sep 30, 2024 | 1,016.00 |